13.25
전일 마감가:
$13.23
열려 있는:
$13.25
하루 거래량:
106.37K
Relative Volume:
0.11
시가총액:
$637.59M
수익:
$128.29M
순이익/손실:
$-30.69M
주가수익비율:
-16.16
EPS:
-0.82
순현금흐름:
$-27.17M
1주 성능:
-2.65%
1개월 성능:
-17.24%
6개월 성능:
-61.28%
1년 성능:
-77.58%
Rxsight Inc Stock (RXST) Company Profile
명칭
Rxsight Inc
전화
949-521-7822
주소
100 COLUMBIA STREET, ALISO VIEJO
RXST을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RXST
Rxsight Inc
|
13.26 | 637.59M | 128.29M | -30.69M | -27.17M | -0.82 |
![]()
ABT
Abbott Laboratories
|
134.29 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
105.76 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
392.97 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.01 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.10 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2025-04-15 | 개시 | Piper Sandler | Neutral |
2025-04-09 | 다운그레이드 | UBS | Buy → Neutral |
2025-04-04 | 다운그레이드 | JP Morgan | Overweight → Underweight |
2025-04-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
2024-12-20 | 다운그레이드 | Stifel | Buy → Hold |
2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2024-12-06 | 개시 | UBS | Buy |
2024-10-29 | 개시 | Jefferies | Buy |
2024-08-20 | 재확인 | Needham | Buy |
2024-08-06 | 재확인 | Needham | Buy |
2024-05-07 | 재확인 | BTIG Research | Buy |
2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2023-12-12 | 개시 | Stifel | Buy |
2023-12-04 | 개시 | Morgan Stanley | Overweight |
2023-04-13 | 개시 | Oppenheimer | Outperform |
2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-08 | 개시 | Needham | Buy |
모두보기
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight Inc (RXST) Shares Up 3.63% on Jun 18 - GuruFocus
FMS or RXST: Which Is the Better Value Stock Right Now? - sharewise
Market Insight: RxSight Inc (RXST)’s Notable Drop, Closing at 13.50 - DWinneX
The Price Is Right For RxSight, Inc. (NASDAQ:RXST) - simplywall.st
When (RXST) Moves Investors should Listen - news.stocktradersdaily.com
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Hold” by Analysts - Defense World
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued - MSN
RxSight Stock: Valuation Blowout Creates Opportunity (NASDAQ:RXST) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,140 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight Inc (RXST) Stock Price Down 3.04% on Jun 4 - GuruFocus
Where are the Opportunities in (RXST) - news.stocktradersdaily.com
RxSight Inc (RXST) Shares Down 7.27% on May 30 - GuruFocus
Midday Stock Roundup: Tilly’s Up 14% Ahead of Q1 Results - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Nuveen Asset Management LLC - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight at Stifel Forum: Navigating Market Challenges By Investing.com - Investing.com Canada
RxSight, Inc. (NASDAQ:RXST) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
RxSight (NASDAQ:RXST) Stock Price Down 4.7% – Here’s Why - Defense World
(RXST) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Do Options Traders Know Something About RxSight Stock We Don't? - TradingView
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire
RxSight (NASDAQ:RXST) Upgraded to Overweight at Wells Fargo & Company - Defense World
RxSight Inc (RXST) Stock Price Up 13.14% on May 19 - GuruFocus
Sector Update: Health Care - marketscreener.com
RxSight Shares Rise After Upgrade From Wells Fargo - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 By Investing.com - Investing.com Canada
RXST Sees Rating Upgrade and Price Target Increase by Wells Farg - GuruFocus
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings) - Benzinga
Wells Fargo Upgrades RxSight (RXST) - Nasdaq
Wells Fargo Upgrades RxSight to Overweight From Equalweight, Lifts Price Target to $25 From $17 - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 - Investing.com Australia
Wells Fargo Upgrades RxSight (RXST) with Increased Price Target | RXST Stock News - GuruFocus
RxSight (RXST) Receives Upgrade from Wells Fargo with Increased Price Target | RXST Stock News - GuruFocus
Wells Fargo upgrades RxSight on ‘strong first-mover advantage’ - TipRanks
RxSight Inc (RXST) Stock Price Up 5.15% on May 16 - GuruFocus
Northern Trust Corp Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : RxSight, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Price T Rowe Associates Inc. MD Sells 23,863 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating - marketscreener.com
RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Dimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Insiders Who Purchased US$1.42m Of RxSight Stock May Not Have Expected 12% Tumble - simplywall.st
Rxsight Inc (RXST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rxsight Inc 주식 (RXST) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
자본화:
|
볼륨(24시간):